Anti-SARS-CoV-2 Nucleocapsid Human Monoclonal Antibody [clone: N22IgA]

Supplier: Genscript
Ratings: (No Reviews)

Total Ratings: 0
Avg. Ratings: 0.0 out of 5

A02090-1 A02090-100
77007-636EA 4000.44 USD
77007-636 77007-518
Anti-SARS-CoV-2 Nucleocapsid Human Monoclonal Antibody [clone: N22IgA]
Antibodies
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). Nucleocapsid Protein is a most abundant structure protein of the coronavirus which is associated with nucleic acid. SARS-CoV-2 Nucleocapsid Antibody (N22IgA), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.

  • High specificity
  • High affinity
  • High stability

Genscript offers site-specific neutralizing antibodies, neutralizing antibody standards, and control antibodies.

Type:
Antigen: SARS-CoV-2 Nucleocapsid
Clonality: Monoclonal
Clone: N22IgA
Conjugation:
Epitope:
Host: Human
Isotype: IgA
Reactivity:
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR